Related Experiment Videos

The akt kinase: molecular determinants of oncogenicity

M Aoki1, O Batista, A Bellacosa

  • 1Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, BCC239, La Jolla, CA 92037, USA.

Insights

The serine-threonine kinase Akt, activated by PI 3-kinase, drives oncogenic transformation. Its plasma membrane localization and kinase activity are crucial for this cancer-promoting role.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Signal transduction pathways

Background:

  • The serine-threonine kinase Akt is a key downstream effector of phosphoinositide 3-kinase (PI 3-kinase).
  • Akt activation is mediated by phosphoinositide-dependent kinases (PDK1 and PDK2).

Purpose of the Study:

  • To investigate the role of Akt in oncogenic transformation.
  • To determine the mechanisms by which Akt contributes to cancer development.

Main Methods:

  • Utilized chicken embryo fibroblast cultures and young chickens for experimental models.
  • Employed mutated forms of Akt to study oncogenic transformation.
  • Investigated the impact of Akt localization and kinase activity on cellular transformation.
  • Assessed the effect of a transdominant negative Akt form on PI 3-kinase-induced oncogenicity.

Main Results:

  • Mutated Akt forms induced oncogenic transformation in cell cultures and hemangiosarcomas in chickens.
  • Akt's plasma membrane localization and kinase activity were essential for its transforming ability.
  • A transdominant negative Akt interfered with PI 3-kinase-driven oncogenic transformation.

Conclusions:

  • Akt is a critical mediator of PI 3-kinase-induced oncogenicity.
  • Targeting Akt signaling may offer therapeutic strategies for cancers driven by PI 3-kinase.
  • Understanding Akt's role in oncogenesis provides insights into cancer development.

Related Concept Videos